Dr. Cheryl Pegus Takes Leadership Role in New Duke-Margolis Health Capital Impact Council

In a significant move towards enhancing health outcomes through strategic investments, Dr. Cheryl Pegus, MD, MPH, has been appointed as the Co-Chair of the newly established Capital Impact Council (CIC) at the Duke-Margolis Center for Health Policy. As the Executive Board Chair of FlyteHealth, Dr. Pegus brings a wealth of knowledge and expertise aimed at transforming the healthcare landscape.

The CIC is designed to unite venture capital and private equity investors with advisory board members to develop best practices that foster investments leading to substantial health advancements within communities. Dr. Pegus emphasized the importance of aligning private investments with broader goals of affordability, sustainability, and lasting health benefits during her inaugural remarks. "Private investment has enormous opportunity to drive innovation in health care, but to be truly transformative those investments must align with larger goals for affordability, sustainability, and long-term health outcomes," she stated.

This initiative is particularly crucial in today's healthcare environment, where the need for effective solutions to complex health issues is increasingly urgent. As healthcare costs continue to rise, the availability of accessible and affordable care becomes ever more vital. The Capital Impact Council aims to address this by devising strategies and frameworks that can ensure measurable improvements in health outcomes, access, and community resilience.

Alongside the announcement of her co-chair position, the CIC released a comprehensive resource titled, "Health Value Return on Investment: A Framework to Support Private Investment that Improves Health Care and Health." This document is instrumental in guiding stakeholders in assessing and evaluating the long-term return on investment (ROI) associated with healthcare innovations. It serves as a critical tool for understanding how investment decisions can be aligned with health-enhancing outcomes.

FlyteHealth, where Dr. Pegus currently serves as Executive Board Chair, specializes in providing obesity care through a holistic approach that combines clinical care, technological support, and behavioral coaching. Through their innovative Flyte Intelligence platform, the organization empowers healthcare providers to deliver personalized treatment options that not only target weight loss but also aim to mitigate related health complications such as diabetes and hypertension.

The expertise and experience that Dr. Pegus brings to the Duke-Margolis Capital Impact Council are seen as pivotal in creating effective public-private partnerships that can ultimately lead to healthier communities. By leveraging her leadership skills, FlyteHealth's mission of simplifying the complexities of obesity care can potentially align with the Council's goals of advancing community health.

For those interested in following the developments of the Capital Impact Council, further information can be accessed through the Duke-Margolis website at Duke-Margolis Health Policy.

As we move forward, the collaboration between health policy leaders and the investment sector will become increasingly important in navigating the challenges of modern healthcare. Dr. Pegus's dual role at FlyteHealth and the Duke-Margolis Center underscores the critical intersection of innovative healthcare solutions and impactful investments, setting a promising foundation for future progress in health equity and accessibility.